The price of insulin has emerged as a big campaign topic ... That same month, the FTC published a report describing PBMs as ...
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs.
The Federal Trade Commission Friday announced it was suing the country's three biggest pharmacy benefit managers, claiming ...
The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made ...
A deal for Intel would be massive and come at a time when the chip maker is sputtering. Ted Colbert led the unit plagued by losses, production delays and the Starliner program that stranded two ...
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms ...
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
The Federal Trade Commission is accusing three companies of artificially inflating insulin list prices. We have new developments on a deadly Israeli strike in Lebanon. The Food & Drug Administration ...
The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
The Federal Trade Commission on Friday filed lawsuits against three prescription drug benefit managers or PBMs over concerns ...
The federal government is suing three big pharmacy benefit managers (PBMs) over a system of drug rebates that regulators say ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback